Integrating preventive oral health with medical care
Our purpose is to improve the oral health of adults with Special Needs, Complex Needs and Geriatric Needs, using a painless, cost-effective treatment of oral dysbiosis (the primary cause of poor oral health). These high risk communities account for 4 in 10 adults.
Their unmet need for better oral health is amongst the largest in pharmaceuticals.
CHX is a pharmaceutical company developing and marketing a new treatment for oral dysbiosis – the primary cause of poor oral health.
Prevora is a high-strength, long-lasting antiseptic topically applied by the hygienist to the teeth of adults at high risk of poor oral health.
Better Outcomes, Lower Cost
Prevora is a profoundly new approach to oral healthcare. It deals with the cause not the consequence of poor oral health.
The Ontario Centre for Excellence and CHX co-fund Mount Sinai Hospital’s review of its Special Care dental program.
New models are needed
For many years, British adults have been offered “free” dental care under the National Health Service (NHS). This is just…Read More